- Home
- For Healthcare Professionals
- For Nurses
- Refer a Patient
-
Clinical Programs and Services
- Adolescent & Young Adult (AYA) Program
- Anesthesiology Program
- BMT and Cellular Immunotherapy Program
- Breast Oncology Program
- Cardio-Oncology Program
- Cutaneous Oncology Program
- Endocrine Oncology Program
- Endoscopic Oncology Program
- Gastrointestinal Oncology Program
- Genitourinary Oncology Program
- Gynecologic Oncology Program
- Head and Neck Oncology Program
- Immunotherapy Program
- Malignant Hematology Program
- Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System
- Neuro-Oncology Program
- Pathology
- Pharmacy
- Radiation Oncology Program
- Radiology – Diagnostic Imaging and Interventional Radiology Program
- Sarcoma Program
- Senior Adult Oncology Program
- Screening & Prevention
- Supportive Care Medicine Program
- Thoracic Oncology Program
- Continuing Education
- Physician Relations
-
Clinical Perspectives
-
Clinical Perspectives Story Archive
- Moffitt's Position on Breast Cancer Screening Guidelines
- Improving Outcomes with Personalized Radiation Therapy for Breast Cancer Patients
- Robotic-Assisted Thoracic Surgery, Not Surgery by the Robot
- Visualase MRI-Guided Laser Ablation For Minimally Invasive Neurosurgery
- Surgical Approaches to Pancreatic Cancer
- Blocking Immune Checkpoints in Glioblastoma
- Surgical Navigation Between Brain Tumors: A Balancing Act
- A Practical Approach To Better Control Of Seizures
- AYA Initiative Aims To Help Those In The Middle
- Drug Increases Red Blood Cell Production, Reduces Transfusion Burden in Patients with Myelodysplastic Syndromes
- Controversy Surrounding Mammography Screening? Not in Our Opinion.
- Moffitt Cancer Center Offers “Personalized” Breast Care Screening
- Moffitt Physicians Team Together to Open the Melanoma Brain & Spine Tumor Clinic
- Integrating Emotional Intelligence for Medical Students
- Moffitt Uses Optical Biopsy to Identify Cancer Faster & Help Patients Avoid Unnecessary Surgery
- Moving Forward in Genitourinary Oncology
- Thyroid Nodule and Cancer Update
- Advanced Gastrointestinal Endoscopy
- Robotic Surgery for Cancer Improves Outcomes
- Pancoast Tumors of the Lung
- Scarless Gynecologic Oncology Surgery
- Thoracic Immunotherapy Trial Portfolio
- Haploidentical Hematopoietic Cell Transplantation for Hematologic Disorders
- Lung Cancer Screening: A new standard of care?
- Putting Personalized Medicine Into Practice
- NEJM Features Lutetium-177-Dotatate for Midgut Neuroendocrine Tumors
- Tumor Treating Fields for Glioblastoma
- Research Continues Following Promising Results of a Vaccine Targeting HER2
- Conference Recap: A Weekend of Dermatopathology
- FDA Approved First CAR-T Gene Therapy
- Geriatric Oncologists Support the Increasing Numbers of Older Cancer Patients
- Tampa Magazine Honors More Than A Dozen Top Moffitt Doctors
- Pathology Getting Personal: Bridging the Gap
- The Holistic Healer
- Second Cytoreductive Surgery/HIPEC Found to Provide Significant Benefit
- What You Need to Know Today About Yescarta
- Outcomes Published on Maximum-Safe Resection of Brain Tumors Using Awake Craniotomy
- Surgical Innovations Enhance Smooth Transition for Brain Cancer Patients
- Researcher Spotlight: Daniel Abate-Daga, PhD & CAR T
- Using Immunotherapy to Combat Gynecological Cancers
- Researcher Spotlight: Dr. Clement Gwede & Health Disparities
- Research Spotlight: Dr. Lau reflects on March for Science
- Research Spotlight: Dr. Gonzalez Aims to Improve Quality of Life for Patients
- Research Spotlight: Dr. Cress Offers Insights on Molecular Oncology, SPARK Program
- Research Spotlight: Dr. Enderling Shares Why He Participated in Miles for Moffitt
- Research Spotlight: Dr. Yamoah on the 'Lifelong Commitment' of a Physician Scientist
- Findings Demonstrate the Safety and Efficacy of Anti-PD-1 Antibody Cemiplimab in Cutaneous SCC
- Researcher Spotlight: Shelley Tworoger, PhD & Population Science
- Summit Recap: Global Cardio-Oncology Summit 2018
- Moffitt’s Neurofibromatosis Clinic Celebrates Prestigious Designation
- Researcher Spotlight: Vince Luca, PhD on Receptors, Ligands and the Fate of Cells
- Pembrolizumab Plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- The Personalized Medicine Clinical Service at Moffitt
- Intratumoral Eco-Evolutionary Dynamics at Work in Dysfunctional Vascular Architecture
- Celebrating Women in Medicine
- Researcher Spotlight: Katarzyna Rejniak Says Teaching is Most Rewarding When Students are Recognized
- New Tampa Bay Surgical Oncology Brings a Valuable Resource to the Region
- Advances in Treatment of HER2-Positive Metastatic Gastric/Gastroesophageal Junction (GEJ) Adenocarcinoma with Combination of Immunotherapy
- Up to 85 Percent of Patients with Cancer Experience Malnutrition or Weight Loss
- Combining Immunotherapy in Triple Negative Breast Cancer Treatment
- What You Missed from ASCO 2019
- Moffitt Oncologists Add Oncolytic Virus to Neoadjuvant Chemo to Treat Triple-Negative Breast Cancer
- Nivolumab Combination Therapy May Increase Efficacy in Metastatic Melanoma Treatment
- Harnessing Immune Response in Advanced Ovarian Cancer
- Assessing Strategies and Challenges in Newly Diagnosed and Recurrent Ovarian Cancer
- SOLO-1 Paves Path for Frontline Maintenance in Ovarian Cancer
- Expert Explains Evolving Strategies in Ovarian Cancer
- Screening and Early Detection in Pancreatic Cancer Outcomes
- Advances in Breast Cancer Immunotherapy Research for Brain-Metastatic Breast Cancer
- Fiducial Markers Support Image-Guided Radiation Therapy
- Updates in Advanced Gastric Cancer Treatment
- Guidelines for Colon Cancer Screening
- Advancements in Melanoma
- Innovative 3D Visualization Technology Enhances Brain Cancer Treatment
- Is Neoadjuvant Chemo Becoming Standard of Care for Advanced Ovarian Cancer?
- MEDx Talk: Evolutionary Therapy in Cancer
- Overall Response Worse for Patients Following Bridging Therapy Prior to CAR T
- Genetic Subtypes of AML Being Explored for Response to CPX-351
- CD47 Antibody Magrolimab in Combination with Azacitidine Effective in MDS and AML Patients
- Department of Defense Funds Study of the Immune-Oncologic Profile of Lethal Prostate Cancer in African American Men
- Advances in Treatment of Recurrent Non-Muscle Invasive Bladder Cancer
- Novel Drug Delivery Tool Enhances Treatment of Recurrent Glioblastoma
- Innovative Therapeutic Treatment of Brain Cancer - Phase 0 Clinical Trial 'Window of Opportunity'
- Grand Opening of New Moffitt Clinic Dedicated to Immune Cell Therapy
- Virtual Oncology Visits Are Up 5,000% at Moffitt— Are They Here to Stay After COVID-19?
- The Moffitt STAR™ Solid Tumor Assay as a Tool to Guide Clinical Decisions
- Moffitt’s Molecular Biology Lab Creates Own COVID-19 Diagnostic Test
- Computational Mass Spectrometry Drives Translational Discoveries in Lung Cancer
- Novel Role of Specific Histone Deacetylase in Non-Small Cell Lung Cancer Discovered
- Collaboration on New Developments for Robotic Lung Surgery Computer Interface
- Moffitt Researchers Utilize the Genomic-Adjusted Radiation Dose to Personalize Radiotherapy in Cancer Care
- Veliparib Monotherapy Study Suggests Benefits for Advanced HER2 Negative Breast Cancer Patients
- Stereotactic Body Radiation May be a Treatment Option for Unresectable Recurrent Head and Neck Cancers
- Geriatric Oncology Offers Prolonged Life Spans for Older Cancer Patients
- Researchers Use Intratumor Heterogeneity to Understand Eco-evolutionary Dynamics of Tumors
- TIL Immunotherapy Offers Promising Results in Metastatic Non-Small Cell Lung Cancer
- Preclinical Research Uses Oncolytic Adenovirus That Selectively Kills Cancer Cells While Revving Up The Immune System
- Artificial Intelligence Achieves Human-Level Performance on Several Natural Language Processing Pathology Benchmarks
- Optimizing Cancer Care Using Digital Technologies Requires Coordinated Multi-Stakeholder Effort
- PARP Inhibitors Improve Survival Rate in Some Relapsed Ovarian Cancer Patients
- Exploring Application of TILs for Head and Neck Cancers
- The World’s First T-cell Therapy for a Solid Tumor Cancer is Poised for Approval via Moffitt Partnership
- Moffitt’s HPV Research Impacts Practice and Policy Worldwide
- Prostatic Artery Embolization: A Non-surgical Treatment for Chronic Prostatitis/Chronic Pelvic Pain from Radiation-Induced Prostatitis
- TIL Immunotherapy Clinical Trial Provides Hope for Recurrent or Metastatic Cervical Carcinoma Patients
- Expanding TILs Beyond Melanoma – Sarcoma Study Now Open
- Nonsurgical Treatment of Thyroid Nodules
- Endocrine Effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)
- August is National Immunization Awareness Month
- Targeted Therapy in Thyroid Cancer
- Radioactive Iodine Treatment in Patients with Thyroid Cancer
- The Future of CAR T for Gynecologic Cancers
- CAR T Clinical Trials for Multiple Myeloma Bring Promising New Treatments
- Advancement in Gynecologic Cancer Treatment Using Immune Checkpoint Inhibitors
- The Future of Immune Checkpoint Inhibitors for Genitourinary Cancers
- Novel Treatment for Brain Cancer Using Immune Checkpoint Inhibitors
-
Clinical Perspectives Story Archive
- Subscribe for the Latest Updates
- For Nurses
- Clinical Pathways
- Outcomes
For Nurses
Moffitt Cancer Center’s nurses are involved with every aspect of patient care and research, from prevention and screening to treatment and clinical trials. Our nurses partner with patients and families as part of our multispecialty team to deliver expert and compassionate care to support Moffitt’s mission: to contribute to the prevention and cure of cancer. Learn more
Request an Appointment at Moffitt Cancer Center
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub